You are invited to participate in a research study to help test new treatments for IPF related cough.
The purpose of this study is to evaluate the efficacy of an investigational study drug for treatment of persistent cough in patients with Idiopathic Pulmonary Fibrosis (IPF) and understand the impact on patients cough symptoms over time.
Principal Study Investigator
Charles Fogarty, M.D.
Pulmonologist, Principal Investigator
Spartenburg Medical Research
(888) 550-3078 ext. 101
Do I Qualify?
Must live in the United States
Must be 40+ Years of Age
Have a confirmed diagnosis of IPF from a doctor
Be willing to participate in a clinical trial
Additional criteria will be assess by study staff
Compensation for Participation & Travel will be provided (*subject to qualifying)